Compare PLSE & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | PRLB |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.1B |
| IPO Year | 2015 | 2011 |
| Metric | PLSE | PRLB |
|---|---|---|
| Price | $21.87 | $55.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $22.00 | ★ $53.00 |
| AVG Volume (30 Days) | ★ 289.4K | 133.4K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | N/A | ★ 0.88 |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | $8.56 |
| Revenue Next Year | $287.54 | $6.89 |
| P/E Ratio | ★ N/A | $64.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $30.20 |
| 52 Week High | $26.30 | $68.91 |
| Indicator | PLSE | PRLB |
|---|---|---|
| Relative Strength Index (RSI) | 60.07 | 40.22 |
| Support Level | $13.75 | $51.86 |
| Resistance Level | $26.30 | $68.91 |
| Average True Range (ATR) | 1.34 | 2.32 |
| MACD | 0.19 | -0.56 |
| Stochastic Oscillator | 78.83 | 18.60 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.